Update on prevention of meningococcal disease: focus on tetravalent meningococcal conjugate vaccine

The Annals of Pharmacotherapy
Allana J MehlhornBrandon J Sucher

Abstract

To review the immunogenicity, efficacy, safety, and new recommendations for routine use of the tetravalent meningococcal conjugate vaccine (MCV4). A MEDLINE search (1966-June 2005) was conducted using the key words Neisseria meningitidis and meningococcal vaccines for clinical trials limited to human research published in the English language. Randomized, controlled, multicenter trials were reviewed and included to evaluate the safety and efficacy of MCV4. Additional open-label trials on the use of MCV4 in children less than 24 months of age are included since these studies may be used to support the approval of the vaccine for use in children. Literature on epidemiology and pathology of meningococcal meningitis and the Advisory Committee on Immunization Practices (ACIP) recommendations were also reviewed. MCV4 is approved for active immunization of adolescents and adults between the ages of 11 and 55 years for the prevention of disease caused by N. meningitidis serogroups A, C, Y, and W-135. MCV4 has been shown to have comparable immunogenicity and a similar adverse reaction profile to the tetravalent meningococcal polysaccharide vaccine (MPSV4). It is expected that MCV4 will provide a longer duration of protection from mening...Continue Reading

References

Nov 1, 1996·The Pediatric Infectious Disease Journal·E A KirschB P Giroir
Jan 7, 1997·Proceedings of the National Academy of Sciences of the United States of America·J S SwartleyD S Stephens
May 1, 2001·Clinical and Diagnostic Laboratory Immunology·G F SantosDan M Granoff
May 3, 2001·The New England Journal of Medicine·N E RosensteinJ M Hughes
Dec 12, 2003·The New England Journal of Medicine·Paul A Offit, Georges Peter
Jan 30, 2004·Annual Review of Medicine·Pratima L RaghunathanN E Rosenstein
Jul 28, 2004·BMC Public Health·Ruth Ann Jajosky, Samuel L Groseclose
Aug 25, 2004·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Ronan J MurrayGary D Lum
Feb 11, 2005·The Pediatric Infectious Disease Journal·C Mary Healy, Carol J Baker
Mar 24, 2005·JAMA : the Journal of the American Medical Association·Mike Mitka

Related Concepts

Clinical Trials
Meningococcal Infections
Menactra

Related Feeds

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.